glucagon has been researched along with molsidomine in 2 studies
| Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) | Studies (molsidomine) | Trials (molsidomine) | Recent Studies (post-2010) (molsidomine) |
|---|---|---|---|---|---|
| 26,039 | 1,498 | 3,054 | 2,022 | 148 | 143 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bygrave, FL; Karjalainen, A; Milbourne, EA; Nguyen, L | 1 |
| An, Z; Cherrington, AD; Dardevet, DP; DiCostanzo, CA; Edgerton, DS; Moore, MC; Neal, DW | 1 |
2 other study(ies) available for glucagon and molsidomine
| Article | Year |
|---|---|
Permeable analogues of cGMP promote hepatic calcium inflow induced by the synergistic action of glucagon and vasopressin but inhibit that induced by vasopressin alone.
Topics: Animals; Calcium; Cyclic GMP; Drug Synergism; Glucagon; Liver; Male; Molsidomine; Nitric Oxide; Perfusion; Rats; Rats, Wistar; Vasoconstrictor Agents; Vasodilator Agents; Vasopressins | 1998 |
Effects of the nitric oxide donor SIN-1 on net hepatic glucose uptake in the conscious dog.
Topics: Animals; Blood Glucose; Blood Pressure; Carbon; Dogs; Fatty Acids, Nonesterified; Glucagon; Glucose; Glycerol; Heart Rate; Infusions, Intravenous; Insulin; Lactic Acid; Liver; Liver Circulation; Molsidomine; Nitric Oxide Donors; Portal Vein | 2008 |